Register information Patent

DE file number : 60 2013 084 148.9 (Status: pending/in force, Query started: April 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 084 148.9
96EP file numberEAKZ19 21 0051.9
97EP publication numberEPN3677252
54Designation/titleTIDOSIERSCHEMATA FÜR VERBINDUNGEN DER ECHINOCANDIN-KLASSE
51IPC main classICM
(ICMV)		 A61K 9/19 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 38/08 (2019.01), A61K 38/12 (2006.01), A61K 47/12 (2006.01), A61K 47/18 (2006.01), A61K 47/26 (2006.01), A61P 31/10 (2006.01), A61K 47/10 (2006.01), A61K 9/06 (2006.01), A61K 9/107 (2006.01)
22DE application dateDATMar 14, 2013
96EP application dateEATMar 14, 2013
43Date of first publicationOTJul 8, 2020
Date of publication of grantPETJun 28, 2023
71/73Applicant/ownerINHNapp Pharmaceutical Group Limited, Cambridge, GB
72InventorINRadhakrishnan, Balasingam, Chapel Hill, NC 27517, US; JAMES, Kenneth Duke, Mebane, NC 27302, US; VAIDYA, Anuradha, Raleigh, NC 27616, US; POLOWY, Karen, Raleigh, NC 27609, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261612676 P
Mar 19, 2012
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261707142 P
Sep 28, 2012
Due dateFT
FG		Mar 31, 2026
Annual fee for the 14th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003677252A1
Searchable text: EP000003677252A1
Original document: EP000003677252B1
Searchable text: EP000003677252B1
43Date of first publicationEVTJul 8, 2020
Date of the first transfer into DPMAregisterEREGTJul 8, 2020
Date of the (most recent) update in DPMAregisterREGTFeb 28, 2025
(Show all update days)(Hide all update days)
  • Feb 28, 2025
    • Due date: changed
  • Aug 15, 2024
    • Procedures: New applicant/owner details, New applicant/owner details, 16.07.2024: changed
  • Jul 17, 2024
    • Applicant/owner: changed
    • Procedures: New applicant/owner details, New applicant/owner details, 16.07.2024: new
  • Jun 15, 2024; May 16, 2024; Apr 6, 2024; Feb 29, 2024; Sep 27, 2023; Jul 20, 2023; Jun 14, 2023; Jun 8, 2023; Aug 5, 2021
    • Historical data not available for this/these date(s)
  • Jul 8, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jul 8, 2020  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 20, 2020 Aug 20, 2020 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jun 28, 2023  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Jul 20, 2023 Jul 20, 2023 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Apr 2, 2024 Jun 20, 2024 Details anzeigen
6 New applicant/owner details New applicant/owner details Jul 16, 2024 Aug 22, 2024 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJul 8, 2020
Date of update of the procedureREGTJul 8, 2020
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 20, 2020
Issue numberHN34
YearPJ2020
Publication dateVTAug 20, 2020
Type of publicationPARTBibliographic data
Date of update of the procedureREGTJul 8, 2020
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJun 28, 2023
Date of update of the procedureREGTJun 8, 2023
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJul 20, 2023
Issue numberHN29
YearPJ2023
Publication dateVTJul 20, 2023
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTJul 20, 2023
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTApr 2, 2024
Issue numberHN25
YearPJ2024
Publication dateVTJun 20, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJun 15, 2024
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 16, 2024
Issue numberHN34
YearPJ2024
Publication dateVTAug 22, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHNapp Pharmaceutical Group Limited, Cambridge, GB
71/73Previous applicant/ownerINHFCidara Therapeutics, Inc., San Diego, CA, US
Date of update of the procedureREGTAug 15, 2024